Quarterly Results

Quarters :

Glenmark Pharmaceuticals Ltd
BSE Code 532296 ISIN Demat INE935A01035 Book Value (₹) 848.31 NSE Symbol GLENMARK Div & Yield % 0.14 Market Cap ( Cr.) 51,930.59 P/E * 35.29 EPS * 52.14 Face Value (₹) 1
* Profit to Earning Ratio
* Earning Per Share
ParticularsSep 2025Jun 2025Mar 2025Dec 2024
  Cr Cr Cr Cr
1,219.532,178.901,909.942,208.84
319.13216.0399.5642.44
285.7669.3488.45129.19
1,824.422,464.262,097.952,380.47
2,648.451,990.001,848.131,757.35
-824.04474.26249.81623.12
23.4015.4613.138.46
-847.43458.80236.68614.65
58.9357.6455.5355.16
-70.1770.17-25.6295.26
0.000.000.000.00
-97.010.7759.0250.43
-739.19330.23147.76413.80
-931.79-266.07-120.800.00
192.60596.30268.56413.80
     
-26.1911.705.2414.66
-26.1911.705.2414.66
-26.1911.705.2414.66
-26.1911.705.2414.66
-104.7846.8120.9458.66
-104.7846.8120.9458.66
0.000.000.000.00
0.000.000.000.00
28.2228.2228.2228.22
0.000.000.000.00
1.001.001.001.00
     
0.000.000.000.00
0.000.000.000.00
     
0.000.000.000.00
0.000.000.000.00
0.000.000.000.00
     
0.000.000.000.00
0.000.000.000.00
0.000.000.000.00
     
-67.5721.7713.0828.21
-69.4921.0612.3927.83
-60.6115.167.7418.73